Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR1,175.00 price target on Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE